Oxford BioMedicaOXBDF 72 Days Inventory is 49.41 as of Dec. 2025, which is 10% below its 10-year median of 54.82. GuruFocus rates OXBDF with a GF Score™ of 72/100 and a GF Value™ of $7.14 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Oxford BioMedica ranks better than 85.11% on this metric.
The historical rank and industry rank for Oxford BioMedica's Days Inventory or its related term are showing as below:
OXBDF'
s Days Inventory Range Over the Past 10 Years
Min: 34.89 Med: 54.82 Max: 93.42
Current: 55.05
During the past 13 years, Oxford BioMedica's highest Days Inventory was 93.42. The lowest was 34.89. And the median was 54.82.
OXBDF's Days Inventory is ranked better than 85.11% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs OXBDF: 55.05
Oxford BioMedica's Days Inventory
declined
from Dec. 2024 (64.30) to Dec. 2025 (49.41).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Oxford BioMedica's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.69.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oxford BioMedica's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.17.
Oxford BioMedica (OTCPK:OXBDF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Oxford BioMedica's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Oxford BioMedica's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Oxford BioMedica Days Inventory Related Terms
Oxford BioMedica Days Inventory Historical Data
* Premium members only.
The historical data trend for Oxford BioMedica's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OXBDF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Oxford BioMedica's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford BioMedica Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford BioMedica's Days Inventory distribution charts can be found below:
* The bar in red indicates where Oxford BioMedica's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford BioMedica (OXBDF) has a Days Inventory of 49.41 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oxford BioMedica and its competitors. This is 10% below median its historical median of 54.82. Over the past decade, Oxford BioMedica's Days Inventory has ranged from 34.89 to 93.42. According to the industry distribution chart, Oxford BioMedica ranks #95 out of 638 companies in the Biotechnology industry, placing it in the top 14.9%.
Is Oxford BioMedica's Days Inventory too high?
Oxford BioMedica's current Days Inventory of 49.41 is 10% below median its 10-year median of 54.82. Over the past 10 years, this metric has ranged from a low of 34.89 to a high of 93.42. The Biotechnology industry median Days Inventory is 183.88. Oxford BioMedica's value of 49.41 is 73.1% below this industry median. Based on the distribution chart, Oxford BioMedica ranks #95 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Oxford BioMedica has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oxford BioMedica's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford BioMedica ranks #95 out of 638 companies for Days Inventory. This places Oxford BioMedica in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.88. Oxford BioMedica's value of 49.41 is 73.1% below this benchmark. Historically, Oxford BioMedica's own Days Inventory has ranged from 34.89 to 93.42 over the past decade. While the company's 10-year median is 54.82 vs. the industry median of 183.88, Oxford BioMedica has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford BioMedica's current Days Inventory of 49.41 is 73.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oxford BioMedica and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford BioMedica's current Days Inventory is 49.41, which is 10% below median its own 10-year median of 54.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioMedica stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioMedica (OXBDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $7.14, compared to a current price of $7.93 — trading 11% above its estimated fair value. The current Days Inventory is 49.41, which is 10% below median its 10-year median of 54.82 and 73.1% below the Biotechnology industry median of 183.88. Oxford BioMedica's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Oxford BioMedica (OXBDF), the current Days Inventory is 49.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxford BioMedica (OXBDF) Overvalued in 2026?
Based on GuruFocus' analysis, Oxford BioMedica stock appears to be overvalued.
The current stock price of $7.93 is trading 11% above its estimated GF Value™ of $7.14.
GuruFocus considers Oxford BioMedica to be Modestly Overvalued.
Key valuation signals for OXBDF:
Days Inventory: 49.41 (10% below median its 10-year median of 54.82)
GF Value™: $7.14 vs. price of $7.93 (11% above fair value)
Industry Position: 73.1% below the Biotechnology median (#95 of 638)
No single metric tells the full story. See the OXBDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. Geographically, it derives maximum revenue from the United States, and the rest from Europe, the UK, and the Rest of the world.
72GF Score
Get the complete analysis for OXBDF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OXBDF has been successfully added to your 
